NATIONAL CENTER OF BIOPRODUCTS

Trials shown by sponsor

Public title	Date of Registration	State
Biomodulina T in pediatric septic shock. Exploratory study	03/08/2020	Registered
Biomodulina T - IM- covid-19 - older adultos - Phase IV clinical trial	05/05/2020	Registered
Combifer vs Trofin phase II in anemic pregnant women.	08/04/2015	Registered
Biomodulin T in older adult for protection in events of local transmission of COVID-19	10/09/2020	Registered
Combifer vs NeotrofinCF-Anemia-Pregnant-Phase II	13/04/2015	Registered
Evaluation of Biomodulin T sublingual Vs intramuscular in the elderly.	13/04/2015	Registered
Combifer-T, Trofin and Ferrous Fumarate in iron-deficiency anemia in pregnant women.	14/01/2019	Registered
VALERGEN-combination of routes- Asthma-Adults-Phase II	14/02/2019	Registered
Subcutaneous immunotherapy with PROLINEM-DS-Asthma- Adults-Fase II	14/06/2018	Registered outdated
Biomodulin T Intramuscular for Thymus Hypoplasia in Children. Phase III	14/08/2017	Registered outdated
Efficacy of nasal provocation test with VALERGEN-DP, DS and BT	15/04/2019	Registered outdated
Evaluation of Biomodulin T® in patients with HIV/AIDS. Phase II/III.	15/08/2018	Registered outdated
Combined sublingual immunotherapy VALERGEN-DP and VALERGEN-BT-Asthma-Adults-Phase II	17/02/2017	Registered
BIOMODULINA T in a long-lived population at high risk of COVID-19 infection	19/09/2020	Registered
Efficacy of VALERGENT-BT subcutaneous vaccine in asthmatic adults	2010-12-07	Registered
Efficacy of VALERGEN-DP subcutaneous vaccine in asthmatic adults	2010-12-07	Registered
Efficacy of VALERGEN-DS subcutaneous vaccine in asthmatic adults.	2010-12-07	Registered
Efficacy of VALERGEN-BT sublingual vaccine in asthmatic adults.	2010-12-08	Registered
Efficacy of VALERGEN-DS sublingual vaccine in asthmatic adults	2010-12-08	Registered
Evidence of the clinical efficacy of VALERGEN-DS vaccine in asthmatics.	2010-12-09	Registered

Registered Trials

Registration process

NATIONAL CENTER OF BIOPRODUCTS

About the RPCEC

Useful resources